SIGYN THERAPEUTICS, INC. Restricted Cash and Cash Equivalents
SIGYN THERAPEUTICS, INC. (SIGY) had Restricted Cash and Cash Equivalents of $25.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-11-09
- 2020-09-30: Restricted Cash and Cash Equivalents $25.00K.
- 2020-06-30: Restricted Cash and Cash Equivalents $25.00K.
- 2020-03-31: Restricted Cash and Cash Equivalents $25.00K.
- 2019-12-31: Restricted Cash and Cash Equivalents $25.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-09-30 | $25.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $25.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $25.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $25.00K 10-K · filed 2020-03-30 |
| 2019-03-31 | $25.00K 10-Q · filed 2019-04-19 |
| 2018-12-31 | $25.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $25.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $25.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $25.00K 10-Q · filed 2018-05-15 |